Muscle fibres are very specialised cells with a complex structure that requires a high level of organisation of the constituent proteins. For muscle contraction to function properly, there is a need for not only sarcomeres, the contractile structures of the muscle fibre, but also costameres. These are supramolecular structures associated with the sarcolemma that allow muscle adhesion to the extracellular matrix. They are composed of protein complexes that interact and whose functions include maintaining cell structure and signal transduction mediated by their constituent proteins. It is important to improve our understanding of these structures, as mutations in various genes that code for costamere proteins cause many types of muscular dystrophy. In this review, we provide a description of costameres detailing each of their constituent proteins, such as dystrophin, dystrobrevin, syntrophin, sarcoglycans, dystroglycans, vinculin, talin, integrins, desmin, plectin, etc. We describe as well the diseases associated with deficiency thereof, providing a general overview of their importance.
Introduction
The concept of the costamere as a morphological structure in striated muscle was first introduced by Pardo et al. in 1983 (Ref. 1) . The observation under an electron microscope of protein bands perpendicular to the longitudinal axis of the muscle fibre, reminiscent of ribs ('costa' in Latin), led them to coin the name costamere (Ref. 1) . It was found that these structures are located at the subsarcolemmal level, aligned with the myofibril Z-discs (Refs 1, 2, 3). Similar structures are oriented transversely over the M lines of the contractile apparatus and oriented parallel to the long axis of the myofibre (Ref. 4) (Fig. 1) .
Functions of costameres
Possible functions of costameres may include the assembly and stabilisation of sarcomeres (Refs 1, 5, 6). Specifically, these protein complexes, associated with the sarcolemma, enable muscle adhesion to the extracellular matrix (Ref. 7) and provide mechanical linkage. This linkage both distributes contractile forces from the sarcomere to the basal lamina ('inside-out') (Refs 5, 6) and transmits externally applied forces to the extracellular matrix inside the myocytes ('outside-in') (Ref. 8) . Given this, it could be expected that defects in costameres would compromise muscle strength directly. These defects would reduce the efficiency of the transmission of lateral forces, and/or indirectly, increase the likelihood of damage to the sarcolemma, resulting in degeneration or death of the myofibre (Ref. 4).
The process of sarcomere assembly is complex and remains poorly understood (Ref. 9). In the initial stages of assembly, there are small aggregates associated with the membrane, known as Z-bodies, which will mature into Z-discs (Ref. 10). Integrins, α-actinin and the constituents of binding sites for integrin, vinculin and talin are the first proteins that can be observed with a periodic pattern in the plasma membrane (Refs 11, 12). There is abundant evidence suggesting that integrin-binding sites are where myofibril assembly starts in vivo. Sparrow and Schock (Ref. 13) suggested that, within the myofibril maturation process, protocostameres are the site of early integrin binding and, hence, of the initiation of myofibril assembly, although other authors proposed an alternative model based on the assembly of multiple latent protein complexes (Ref. 9).
The correct alignment of costameres with the Z-and M-lines is dependent on other structures in the network of filamentous proteins of the cytoskeleton, namely, the family of the intermediate filaments (IFs) (Refs 14, 15). These are responsible for binding between the sarcolemma and the myofibrils adjacent to the Z-lines (Refs 16, 17, 18) and presumably also the M-lines (Refs 16, 19) . Desmin, together with other associated proteins, synemin and paranemin, form the IFs of the Z-lines (Refs 20, 21) (Fig. 1) . The complex process of assembly is genetically regulated by a specific process that involves transcription factors: myocyte enhancer factor-2 (MEF2), serum response factor (SRF) and histone deacetylase (Ref. 22) .
First, MEF2 is a transcription factor (Refs 23, 24, 25) required for the terminal differentiation of cardiac, skeletal and smooth muscle (Refs 26, 27, 28). MEF2A, in particular, plays an essential role in muscle regeneration in adult mice through direct regulation of the microRNA cluster, the Gtl2-Dio3 locus. To summarise, the assembly of sarcomere proteins is a highly regulated, complex and delicate process, depending on many factors, and abnormalities in these factors, for example, as a result of mutations of genes coding for some of their components, produce a range of different myopathic processes (listed in Table 1 ). Below, we describe the main constituent proteins of costameres, their location within the cell and their involvement in these myopathic processes.
Main components of costameres
Costameres are principally composed of two complexes, the dystrophin-glycoprotein complex and the vinculin-talin-integrin system. Both regulate the interaction between the cytoskeleton and the extracellular matrix in skeletal muscle in adults (Ref. 42).
The intracellular actin fibres, which are part of the contractile apparatus, are bound to laminin of the extracellular matrix by dystrophin (Refs 43, 44, 45, 46). Integrin α7β1, a transmembrane laminin receptor, also helps to link the extracellular matrix and the cytoskeleton (Refs 47, 48, 49) (Fig. 1) .
In addition to the aforementioned two complexes, other proteins, including desmin, plectin and melusin, are involved and these are described in more detail below.
The dystrophin-glycoprotein complex (DGC)
This structural unit is composed of dystrophin and a series of proteins (dystroglycans α and β, sarcoglycans 
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α−ε, sarcospan, syntrophins α1, β1 and β2, and two isoforms of a subsarcolemmal protein, α-dystrobrevin-1 and -2) that form a complex for binding cytoplasmic myofibrillar contractile elements and proteins of the extracellular matrix, providing structural support to the sarcolemma (Refs 50, 51). Other more peripheral components of the complex include neuronal nitric oxide synthase (nNOS), caveolin-3 and laminin α−2 (Refs 42, 52).
In the relation to the DGC complex, three subcomplexes can be identified, on the basis of different biochemical characteristics and localisation: the The sarcoplasmic subcomplex. This is composed of proteins present in the sarcoplasm of muscle fibres, mainly dystrophins, dystrobrevins and syntrophins.
Dystrophin. Dystrophin is a cytoskeletal protein found on the inner surface of the sarcolemma of skeletal muscle (Ref. 54, 55, 56) . Its amino-terminal residue is a cytoplasmic actin-binding domain, whereas the C-terminal domain is associated with a transmembrane complex of glycoproteins called dystrophin-associated glycoproteins (DAGs), some of which interact directly with elements of the extracellular matrix (Ref. 43). Absence or dysfunction of dystrophin leads to an increase in the fragility of the membrane, in turn, weakening the transmission of mechanical forces through the sarcolemma. The result is myofibrillar necrosis, leading to a succession of cycles of degeneration and regeneration, exhausting the regenerative capacity of the muscle. This is accompanied by a loss of myofibrils, muscle being replaced by fibrous and fatty tissue, as observed in patients with Duchenne and Becker muscular dystrophies.
Dystrobrevins. Dystrobrevins are expressed in various types of tissue, including the brain and muscle. The α-dystrobrevin isoform is expressed in muscle and is homologous to the cysteine-rich C-terminal domain of dystrophin (Refs 57, 58). This isoform is directly associated with dystrophin and the sarcoglycan complex (Refs 59, 60). Nevertheless, to date, no myopathies have been described secondary to mutations in the α-dystrobrevin gene (Ref. 
The dystroglycan complex strengthens the physical connection between the cytoplasmic proteins that bind to the actin cytoskeleton and components of the basement membrane, proteins of the extracellular matrix that contain globular domains of laminin (for example, laminin, agrin and neurexin) (Refs 77, 78).
Although genetic dystroglycan deficiency leads to muscular dystrophy with cognitive impairment (Ref. 79) , several forms of congenital muscular dystrophy are the result of abnormalities in the glycosylation of mucin-like domains of α-dystroglycan, essential for its correct functioning as a receptor of the extracellular matrix in various types of tissue, including skeletal muscle and brain (Refs 78, 80) ( Table 1) .
The vinculin-talin-integrin system Vinculin and talin are two cytoskeletal proteins that are essential for the linkage of actin filaments to the plasma membrane (Ref. 81) , whereas integrins are heterodimers composed of two subunits, α and β (Ref. 82 Integrins play an important role in the process of muscular differentiation and, in particular, are mediators of cell adhesion and migration (Ref. 6). Various different heterodimers have been identified, composed of α and β chains. The α/β combination determines the binding specificity of the ligand of the integrin heterodimer for various different proteins of the extracellular matrix, including fibronectin, laminin and collagens. The most common isoforms in skeletal muscle of adults are α7B and β1D, the latter being found with vinculin in skeletal and cardiac muscle (Refs 96, 97). The affinity of integrin for its ligands depends on its activation, this usually occurring through the cytoplasmic tail of β-integrins that can be regulated by various biochemical signalling pathways (Ref. 98) .
During myogenesis, two isoforms of integrin 1β are expressed. The isoform 1A is expressed in myoblasts and is under-expressed during tissue formation, whereas isoform 1D is expressed during fusion and its expression increases during the maturation of myotubes, completely displacing the isoform 1A in mature myotubes (Ref. 96) .
Two types of congenital muscular dystrophy have been found to be because of mutations in genes coding for integrins, one to mutations in ITGA7 (Table 1) .
On the other hand, as previously mentioned, integrins interact with collagens and it is worthwhile to underline that collagen VI plays a fundamental role in costameric function maintenance, given that proteins essential for mechanotrasduction are altered in collagen VI null mice and collagen VI myopathy (Refs 101, 102, 103, 104, 105) ( Table 1) .
Other proteins associated with costameres
As well as the aforementioned complexes, other proteins are indirectly involved in the structure of the costamere, either by being associated with integrins, or by being part of or associated with IFs.
Integrin-associated proteins. These include a complex formed by ILK, particularly interesting cysteine-and histidine-rich protein (PINCH) and parvin, the IPP complex (Ref. 106) .
Regarding the proteins in the IPP complex, ILK regulates integrin-mediated signalling, and PINCH and parvins are adaptor proteins. ILK was identified in 1996 among other proteins that bound to the cytoplasmic region of integrin β1 (Ref. 107) . It is a serine-threonine protein kinase that, as well as binding to PINCH and parvins, also binds to the cytoplasmic regions of integrins β1 and β3, regulating integrin-mediated transduction signal (Refs 107, 108). PINCH has two isoforms, PINCH1 and 2 (Refs 109, 110) and together with ILK, is essential for controlling the change of shape, mobility and survival of cells (Ref. 111) . Parvins are a family of proteins composed of α-parvin (also known as actopaxin and calponin homology-containing ILK-binding protein), β-parvin (affixin) and γ-parvin that bind to ILK through a calponin-homology domain (Refs 112, 113, 114) .
Another integrin-associated protein is melusin, a protein coded by the ITGB1BP2 gene. Melusin binds to the cytoplasmic domain of the integrin β1 subunit in costameres, acting as a specific biomechanical sensor of signal transduction (Ref. 115 ). In the cardiac muscle, the effect of melusin is to prevent heart failure under biomechanical stress (Ref. 116) .
Some mutations in the genes coding for proteins of this complex have been associated with muscular dystrophies (Ref. 117 ) and with heart disease (Refs 118, 119), (Table 1) .
Another protein closely associated with integrins is Plectin, a protein associated with the cytoskeleton, is abundantly expressed in various types of tissue and cell types (Refs 127, 128). It has been suggested that it may interact directly with actin filaments, microtubules, microtubule-associated proteins, α-spectrin, and integrin β4, as well as most IFs (Refs 129, 130, 131) .
Myofibre integrity depends on the desmin network targeting Z-discs and costameres via plectin isoforms. Among the different isoforms of plectin, 1 and 1f are localised at costameres. Plectin deficiency results in desmin detaching from Z-discs, costameres, mytochondria and nuclei; depending on which plectin isoform is lacking, desmin aggregates have a distinct morphology and form in distinct cytoplasmic compartments (Ref. 132) .
Desmin deficiency leads to limb-girdle muscular dystrophy, LGMD2R (Ref. 133 ) and an allelic variant of myofibrillar myopathy (Ref. 134) , whereas plectin deficiency produces LGMD 2Q (Ref. 135) (Table 1) .
Protein potentially associated with costameres. Facioscapulohumeral muscular dystrophy region gene 1 (FRG1) protein is one of a group of proteins whose localisation and function are still to be clearly defined. There is evidence that it participates in the processing of RNA (Ref. 136 ) and it may be involved in F-actin bundling in Caenorhabditis elegans (Ref. 137) . It has been suggested that FRG1 in C. elegans is a multi-function protein present in various subcellular niches, but primarily in nucleoli and dense bodies. In this organism, the most important function of dense bodies is transduction of mechanical forces, essentially by anchoring sarcomeric actin to the extracellular matrix; that is, they are structures with a similar function to that of the combination of Z-discs and costameres in vertebrates (Refs 137, 138) . Therefore, as well as in C. elegans, FRG1 could be involved in costameres in vertebrates.
Summary
The structure and role of costameres and their involvement in the pathophysiology of skeletal muscular disorders are still not well understood. Given that this system includes many molecules closely associated spatially and with two types of function (structural support and signal transduction), it is likely that abnormalities in any of the components have an impact on the stability of the whole system, with consequences for the structure of the membrane, or the functionality of the contractile apparatus, or both at the same time. This has been confirmed in dystrophinopathies, in which the absence of dystrophin leads to the disappearance of dystoglycans/sarcoglycans, and in sarcoglycanopathies, in which the lack of the protein as a result of mutation leads to a secondary reduction or disappearance of the remaining sarcoglycans. Moreover, a similar phenomenon has also been reported when contactin-1 gene is mutated, as this results in reduced expression of β2-syntrophin and α-dystrobrevin (Ref. 139) .
Regarding potential therapies for myopathic processes because of defects in costamere proteins, different approaches have been widely tested. However, clinical trials have only been performed for a few of them. In the case of Duchenne muscular dystrophy (DMD), for example, molecular-based pharmacologic therapies to correct gene products have been applied (Refs 140, 141) . In sarcolgycanopathies, an adenoassociated virus has been used to transfect the exogenous gene (Ref. 142 ) and in collagen VI myopathies, compounds that modulate the activity of the mitochondrial permeability transition pore have been assessed (Refs 143, 144) . Unfortunately, just a few of these approaches showed the sought outcome so far.
Further research is required on selective silencing and at different stages in the processes of myogenesis and differentiation of skeletal muscle in physiological and pathological conditions to clearly establish the role of these structures in skeletal muscle. Current knowledge suggests that these proteins could be therapeutic targets for preventing the 'de-structuring' of the sarcolemma that leads to the degeneration of myofibres in patients with muscular dystrophy. 
